Learn more about Blue Cross Blue Shield of Michigan's commitment to affordability here
The impact varies significantly depending on your sport and training style
"Our SURMOUNT-5 trial, which is a head-to-head trial comparing tirzepatide (Zepbound) and semaglutide (Wegovy) for the treatment of obesity or overweight with weight-related comorbidities, is expected to read out in 2025," a spokesperson said in an email
When you inject the medication, it attaches to the same receptors and triggers similar effects
Some studies on human adipocytes demonstrated that increased fat cell size correlates with impaired whole-body metabolic regulation and systemic insulin resistance
These effects were not considered to be clinically relevant [44, 53, 54] and dose adjustments for co-administered drugs are not required [18, 19]